Dr Anne Poljak is a senior research scientist in the Bioanalytical Mass Spectrometry Facility (BMSF), a research facility within the University of NSW, Proteomics Group team leader in the Centre for Healthy Brain Aging (CHeBA), and lecturer (conjoint) in the School of Medical Sciences UNSW. She applies proteomics and mass spectrometry based techniques to better understand how ageing affects the brain, mechanisms underlying neurodegenerative diseases of ageing, such as Alzheimer’s disease and also to quantify biomarkers which may help identify age related changes and early disease stages. She has authored or co-authored over 60 peer-reviewed articles in leading scientific journals including Scientific Reports, Translational Psychiatry, Proceedings of the National Academy of Sciences and PLoS One. Her research group has interests in proteins, pathways and mechanisms which may protect the ageing brain, including the broad apolipoprotein family group and the sirtuin protein family. Her work is supported by government funding bodies such as the ARC and NHMRC as well as philanthropic funding from groups such as the Rebecca L. Cooper Medical Research Foundation and Alzheimer’s Australia.